# EPINEPHRINE
> **NDA215425** · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2025-03-13
## Drug
- **FDA Application Number:** NDA215425
- **Application type:** New Drug Application
- **Brand name:** EPINEPHRINE
- **Generic name:** EPINEPHRINE
- **Active ingredients:** EPINEPHRINE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2025-03-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215425)
---
*AI Analytics · CC0 1.0*